Using the device also seems to cut rates of HF hospitalization compared with the two comparator groups (P<0.01 and P<0.0001, respectively), Dr Nirav Raval (Florida Hospital Transplant Institute, ...
Abbott Laboratories, Inc. ABT presented new data from an investigator-sponsored European study — MONITOR-HF. The study revealed that Abbott's CardioMEMS HF System led to a significant improvement in ...
NEW ORLEANS — Patients with heart failure (HF) who were implanted with the CardioMEMS (Abbott) pulmonary artery (PA) pressure sensor showed a reduction in hospitalizations after 1 year in the ...
The CardioMEMS HF System is proven to significantly reduce heart failure hospitalizations and improve quality of life in NYHA class III HF patients St. Jude Medical now intends to exercise its ...
Prospective data from the CHAMPION study shows that after 31 months of follow-up, heart failure patients managed with the CardioMEMS HF System had a 48 percent reduction in heart failure ...
ST. PAUL, Minn. -- St. Jude Medical, Inc., a global medical device company, today announced a new data analysis from the CHAMPION clinical trial that evaluated outcomes in a subgroup of patients with ...
Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Patients with HF who were treated with pulmonary artery pressure-guided therapy through ambulatory ...
St. Vincent's Medical Center is now helping doctors and patients with heart failure (HF) manage their health with a tiny, implantable wireless monitoring sensor. The CardioMEMS HF System is the first ...
St. Jude Medical and CardioMEMS are not the only two entities celebrating the FDA approval of the world’s first implantable wireless pulmonary artery pressure sensing device for heart failure patients ...
Keeping heart failure patients healthy and away from the emergency room is a top priority for hospitals seeking to lower costs and prevent Medicare fines resulting from high hospital readmissions ...
NEW ORLEANS (March 17, 2019) -- In the year following placement of a CardioMEMS heart failure sensor--designed to wirelessly measure and monitor pulmonary artery pressures that can signal worsening ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results